NCT04191499 2026-03-17INAVO120Hoffmann-La RochePhase 2/3 Active not recruiting325 enrolled 14 charts 3 FDA
NCT04305496 2026-01-29CAPItello-291AstraZenecaPhase 3 Active not recruiting818 enrolled 19 charts 2 FDA